$710 MillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$26.10 - $60.23The lowest and highst price in the last 52 weeks.
-32.12xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$0.00 (0.0%)Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
|Market Cap||$710 Million|
|Enterprise Value||$897 Million|
|Dividend Yield||$0.00 (0.0%)|
|1 Year Return||+33.3%|
|Outstanding Shares||16.7 Million|
|Avg 30 Day Volume||147 Thousand|
|Earnings per Share||-$1.83|
|Price to Sales Ratio||3.49|
|Price to Book Ratio||3.81|
|Revenue to Enterprise Value||4.22|
|EBIT to Enterprise Value||-286.96|
|Total Debt to Enterprise Value||0.23|
|Debt to Equity||1.06|
|Gross Profit||$121 Million|
|Net Income||-$22.1 Million|
|Quarterly Earnings Growth (YoY)||-1124.7%|
|Return on Equity||-11.55%|
|Return on Assets||-4.7%|
|Return on Invested Capital||-0.81%|
6,572 shares bought (3 transactions)
CEO: Patrick Walsh
Industry: Biological Product (except Diagnostic) Manufacturing
ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. The Company's targeted areas of product development currently include narcotics, oncolytics (anti-cancers), hormones and steroids, and complex formulations involving extended release and combination products.
BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that it has completed the previously announce...Business Wire, about 2 months ago
The Federal Trade Commission (“FTC”) reached a settlement with generic drug companies ANI Pharmaceuticals, Inc. (“ANI”) and Novitium Pharma LLC (“Novitium”),...JD Supra, 2 months ago
Related Stocks: SGC , ANIP , IHI , IYT , CMC , PSQ , T , GE , IJT , RDS.A , SHV , BMY ,GuruFocus, 2 months ago
Squarepoint Ops LLC raised its stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) by 57.6% during the second quarter, according to its most recent filing with ...Dakota Financial News, 2 months ago